GlobeNewswire by notified

Nokia wins deal with MTN to accelerate expansion of 5G in South Africa #MWC23

Share

Press Release

Nokia wins deal with MTN to accelerate expansion of 5G in South Africa #MWC23

  • New deal with MTN South Africa replaces incumbent supplier, strengthens partnership and increases Nokia’s market share.
  • Nokia to deploy its comprehensive AirScale portfolio to modernize and expand MTN’s 5G radio network for superior coverage and capacity.  
  • Nokia to establish a new training program focused on entrepreneurship and digitalization.

27 February 2023

Espoo, Finland – Nokia today announced that it has been selected by MTN South Africa (MTN SA) for the first time ever as one of its 5G Radio Access Network (RAN) equipment providers. Under the deal, Nokia will modernize the existing 2G/3G/4G radio network and expand MTN’s 5G radio network across 2800 sites in the Central and Eastern part of the country – driving digitalization across the African continent. MTN SA is part of MTN Group Limited, Africa's largest mobile network operator with operations in 17 countries serving 272 million subscribers.

Nokia will provide equipment from its next-generation, energy-efficient AirScale portfolio - powered by its latest generation of ReefShark chipsets - including 5G AirScale baseband, massive MIMO active antennas and remote radio heads (RRH) covering all urban and rural scenarios. Nokia will also provide its Self-Organizing Networks (SON) solution for optimization and network assurance, ensuring MTN's network continues to perform optimally. Nokia’s solutions will enable a superior 5G experience for mobile users with high bandwidth, ultra-fast speeds, and low latency.

As part of its commitment to South Africa, Nokia is also establishing a training program to drive digitalization in the country and across the African continent. Open to 5,000 applicants, the program will focus on product development as well as developing entrepreneurship. The program is aligned with the Finnish National Agency of Education and graduates will receive a diploma supporting further career opportunities.

Michele Gamberini, MTN South Africa’s Chief Technology and Information Officer, said: “We need next-generation technologies, such as Nokia’s AirScale portfolio to ensure that South Africa is a leader in the digital era across the African continent and globally. Our partnership with Nokia allows us to rapidly expand our 5G network so that our citizens and their businesses can leverage the digital economy and reap the benefits of a modern connected life.”

Tommi Uitto, President of Mobile Networks at Nokia, said: “This significant contract with MTN strengthens our market position in South Africa and helps MTN deliver superior 5G experiences to its subscribers. Our industry-leading energy-efficient AirScale portfolio will improve the coverage and capacity of MTN’s network performance while contributing to reduced carbon emissions. We look forward to a long-lasting and successful partnership with MTN.”

Resources and additional information
Webpage: AirScale Radio
Webpage: Nokia SON
Webpage: AirScale Indoor Radio
Webpage: AirScale Active Antennas
Press release: Nokia drives MTN Core evolution through cloud and future voice upgrades

Meet us at Mobile World Congress 2023 #MWC23 www.nokia.com/mwc

About Nokia
At Nokia, we create technology that helps the world act together.

As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs.

Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future.

Media Inquiries
Nokia Communications, MEA
Kannan K
Email: kannak.k@nokia.com

Nokia Communications, Corporate
Email: Press.Services@nokia.com

Follow us on social media
LinkedInTwitterInstagramTikTokFacebookYouTube

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Tenaris Announces 2024 First Quarter Results25.4.2024 22:30:25 CEST | Press release

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt, Free Cash Flow and Operating working capital days. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) today announced its results for the quarter ended March 31, 2024 in comparison with its results for the quarter ended March 31, 2023. Summary of 2024 First Quarter Results (Comparison with fourth and first quarter of 2023) 1Q 20244Q 20231Q 2023Net sales ($ million)3,4423,4151%4,141(17%)Operating

Combined General Meeting of May 16, 202425.4.2024 22:30:00 CEST | Press release

Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on May 16, 2024, at 10:00 a.m. CET at the Company’s new headquarters located at IRO Building, 107 Avenue de la République, 92320 Châtillon, France. The preliminary notice (avis de réunion) containing the detailed agenda, draft resolutions as well as instructions to participate and vote for this General Meeting was published in the French “Bulletin des Annonces Légales Obligatoires (BALO)” dated April 8, 2024 (No. 2400716). The meeting notice (avis de convocation) will be published in the BALO and in t

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO25.4.2024 22:30:00 CEST | Press release

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO Luxembourg, April 25, 2024 – Millicom announced today that its Board of Directors has appointed Marcelo Benitez as CEO of Millicom, effective June 1, 2024. Benitez has had a distinguished career with Millicom, having joined the company in Paraguay nearly 30 years ago and risen through the Company’s ranks to his most recent role as CEO of TIGO Panama. Benitez's selection completes the final phase of a succession planning and selection process, which included a thorough evaluation of internal and external candidates to ensure that the company's next CEO possesses the vision, experience, talent and leadership qualities necessary to deliver on Millicom's strategic plans. "After an extensive evaluation, it is clear to our Board that Marcelo is the right person to lead Millicom into the future”, indicated Mauricio Ramos, Chair of the Board of Directors of the Company. Under Marcelo’s leadership, TIGO Panama completed the succ

Mohawk Industries Reports Q1 Results25.4.2024 22:10:00 CEST | Press release

CALHOUN, Ga., April 25, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced first quarter 2024 net earnings of $105 million and earnings per share (“EPS”) of $1.64; adjusted net earnings were $119 million, and adjusted EPS was $1.86. Net sales for the first quarter of 2024 were $2.7 billion, a decrease of 4.5% as reported and 5.5% on a legacy and constant basis versus the prior year. During the first quarter of 2023, the Company reported net sales of $2.8 billion, net earnings of $80 million and EPS of $1.26; adjusted net earnings were $112 million, and adjusted EPS was $1.75. Commenting on the Company’s first quarter results, Chairman and CEO Jeff Lorberbaum stated, “Though economic headwinds are impacting industry sales, margins and mix, our first quarter results reflected the positive effect of actions we are taking to enhance our performance. Our earnings per share rose year over year as a result of restructuring, productivity initiatives and benefits from

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®25.4.2024 22:05:00 CEST | Press release

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA®1. The intravenous formulation of TOFIDENCE has been recommended for approval for the treatment of moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19. The CHMP’s positive opinion will now be referred to the European Commission (EC), which will decide whether to grant marketing authorization for TOFIDENCE. If a marketing authorization is granted by the EC, TOFIDENCE will be an addition to the existing biosimilars portfolio of three widely p

HiddenA line styled icon from Orion Icon Library.Eye